Oliceridine

Oliceridine

by | Jun 2, 2024 | Synthesis of Drugs

FollowFollowFollow Oliceridine Oliceridine is an opioid medication that was approved by the FDA for the treatment of moderate to severe acute pain in adults. The medication is indicated for short-term intravenous use in hospitals and other controlled clinical...
Futibatinib

Futibatinib

by | Nov 3, 2023 | Synthesis of Drugs

FollowFollowFollow Futibatinib Futibatinib is a medication that in September 2022 received accelerated approval by the FDA for the treatment of cholangiocarcinoma. Disease: oncology Target: FGFR – Tyrosine Kinase. Mechanism of Action: Irreversible inhibitor. ...
Bempedoic Acid

Bempedoic Acid

by | Aug 5, 2023 | Synthesis of Drugs

FollowFollowFollow Synthesis of Bempedoic Acid Bempedoic acid is a drug developed by Esperion Therapeutics and approved by the FDA and the European medicines agency for the treatment of hypercholesterolemia. [1] Biology Notes Cholesterol is an essential structural...
Enarodustat

Enarodustat

by | May 27, 2023 | Synthesis of Drugs

FollowFollowFollow Synthesis of Enarodustat Chemical synthesis of enarodustat, a medication that was approved by the Japan Pharmaceuticals and Medical Devices Agency for the treatment of anemia associated with chronic kidney disease. Biology Notes Kidneys produce a...
Synthesis of Lumateperone

Synthesis of Lumateperone

by | May 20, 2023 | Synthesis of Drugs

FollowFollowFollow Synthesis of Lumateperone Chemical synthesis of Lumateperone, a medication that was first approved by the United States Food and Drug Administration (USFDA) for the treatment of schizophrenia in adults and that later demonstrated efficacy in bipolar...
Synthesis of Tegoprazan

Synthesis of Tegoprazan

by | Apr 2, 2023 | Synthesis of Drugs

FollowFollowFollow Synthesis of Tegoprazan Chemical synthesis of Tegoprazan, a drug discovered by Pfizer and developed by RaQualia Pharma and CJ Healthcare for the treatment of gastroesophageal reflux disease (GERD). In 2018 its commercial use was approved in Korea....